Monthly Prescribing Reference: Entresto Approval Expands Use to More HF Patients With LVEF Below Normal Entresto Approval Expands Use to More HF Patients With LVEF Below Normal Medscape: Trials Say Start Sacubitril-Valsartan in Hospital in HF With 'Below Normal' LVEF Trials Say Start Sacubitril-Valsartan in Hospital in HF With 'Below Normal' LVEF “ The improvement in angina and heart failure symptoms in those with near normal LVEF provides a clear benefit to this patient population that is aligned with the FDA’s 2018 decision to expand Impella ... Healio: In HF hospitalization, benefits of sacubitril/valsartan largest in LVEF below normal Healio: Higher sex-specific LVEF may mean better outcomes in women with suspected ischemia Higher sex-specific LVEF may mean better outcomes in women with suspected ischemia